Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : N::A    symbols : RVNC    save search

Global Cell Penetrating Peptide Market Forecast Report to 2030, Featuring Biosynth, Creative Peptides, Cupid Peptide, Alta Bioscience, AnaSpec, Peptomyc, PolyPeptide, Bachem & Sarepta Therapeutics
Published: 2024-02-05 (Crawled : 11:00) - prnewswire.com
SRPT | $116.59 -1.1% -1.12% 500K twitter stocktwits trandingview |
Health Technology
| | O: 0.12% H: 3.45% C: 3.4%
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -2.42% H: 1.05% C: -2.67%

report cell global therapeutics market
Global Facial Injectable Market Analysis Report 2023-2028: New Product Launches, Increased Male Aesthetics, and Emerging Markets Driving Growth
Published: 2023-09-06 (Crawled : 10:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 0.0% C: 0.0%
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.46% H: 1.38% C: -2.87%
EOLS | $11.56 -0.69% -0.69% 340K twitter stocktwits trandingview |
Health Technology
| | O: 0.41% H: 0.92% C: -0.1%

report global growth market
Facial Injectable Global Market Report 2022: Sector to Reach $23.55 Billion by 2027 at a 15.46% CAGR
Published: 2023-03-01 (Crawled : 04:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: -1.29% H: 0.0% C: -0.13%
BHC | $8.6 -0.69% 0.0% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 0.85% C: -1.6%
ABBV | News | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 1.85% C: 1.64%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.0% C: 0.0%
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -3.46% H: 3.43% C: -3.73%

global report market
Global Botulinum Toxin Market Report 2022-2026 with Focus on AbbVie, Daewoong Pharma, HUGEL Pharma, Ipsen, Medy-Tox, Merz Pharma, Metabiologics, Revance Therapeutics, & US WorldMeds
Published: 2022-06-21 (Crawled : 13:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 6.51% H: 0.0% C: 0.0%

report market pharma
Outlook on the Cosmetic Surgery and Procedure Global Market to 2027 - Featuring Bausch Health Companies, Lumenis and Galderma Among Others
Published: 2022-06-07 (Crawled : 16:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.44% H: 3.16% C: 2.93%
EOLS | $11.56 -0.69% -0.69% 340K twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 3.64% C: 0.71%

health market
Worldwide Cosmetic Surgery and Procedure Industry to 2030 - Featuring Galderma, Alma Lasers and Lumenis Among Others
Published: 2022-06-03 (Crawled : 19:00) - prnewswire.com
SIEN | $0.174 0.69% 3.4M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
EOLS | $11.56 -0.69% -0.69% 340K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist


REVANCE THERAPEUTICS 96 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Revance Therapeutics, Inc. - RVNC
Published: 2022-02-05 (Crawled : 04:20) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

ces therapeutics 100 deadline
Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Revance Therapeutics, Inc. (RVNC) That a Securities Fraud Class Action Lawsuit Has Been Filed On Their Behalf
Published: 2022-02-04 (Crawled : 00:20) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

therapeutics deadline
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Revance Therapeutics, Inc. - RVNC
Published: 2022-01-14 (Crawled : 05:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.92% H: 0.0% C: 0.0%

ces therapeutics deadline
RAAS Investors Have Opportunity to Lead Cloopen Group Holding Limited Securities Fraud Lawsuit
Published: 2022-01-04 (Crawled : 19:00) - prnewswire.com
RAAS | $1.13 10.62% 14K twitter stocktwits trandingview |
Information
| | O: -0.37% H: 4.43% C: -5.17%
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.25% H: 0.37% C: -5.83%

group
RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud Lawsuit
Published: 2022-01-04 (Crawled : 19:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.25% H: 0.37% C: -5.83%

therapeutics
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Revance Therapeutics, Inc. - RVNC
Published: 2021-12-31 (Crawled : 05:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 0.85% C: -0.67%

therapeutics deadline
ALERT: Revance Therapeutics, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - RVNC
Published: 2021-12-31 (Crawled : 05:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 0.85% C: -0.67%

therapeutics
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors With Substantial Losses to Contact the Firm
Published: 2021-12-29 (Crawled : 21:00) - prnewswire.com
ZME | $0.6001 0.0% twitter stocktwits trandingview |
Educational Services
| | O: -2.14% H: 8.13% C: 2.38%
RAAS | $1.13 10.62% 14K twitter stocktwits trandingview |
Information
| | O: 0.36% H: 10.11% C: 7.22%
OWLT | $3.91 14.66% 0.0% 10K twitter stocktwits trandingview |
| | O: -6.51% H: 10.18% C: 5.74%
PLTK | News F | $6.87 -0.43% -0.44% 560K twitter stocktwits trandingview |
| | O: -0.35% H: 5.92% C: 4.32%
LSPD | $12.99 -0.84% 0.0% 640K twitter stocktwits trandingview |
Technology Services
| | O: 0.0% H: 6.78% C: 4.47%
STNE | $15.26 0.07% 0.07% 3.8M twitter stocktwits trandingview |
Technology Services
| | O: 0.0% H: 11.42% C: 7.94%
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 3.8% C: -0.42%
ORGO | $2.865 2.69% 2.62% 330K twitter stocktwits trandingview |
Finance
| | O: 0.0% H: 3.05% C: 1.2%
MARA | $15.04 2.8% 2.73% 39M twitter stocktwits trandingview |
Commercial Services
| | O: 0.19% H: 5.96% C: 1.22%

deadline
RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc.
Published: 2021-12-25 (Crawled : 00:20) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

therapeutics deadline
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Revance Therapeutics, Inc. - RVNC
Published: 2021-12-17 (Crawled : 01:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -3.44% H: 0.0% C: 0.0%

therapeutics deadline
DEADLINE: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RVNC
Published: 2021-12-15 (Crawled : 05:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.11% H: 0.0% C: 0.0%

therapeutics deadline
DEADLINE: Organogenesis Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ORGO
Published: 2021-12-15 (Crawled : 05:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.11% H: 0.0% C: 0.0%
ORGO | $2.865 2.69% 2.62% 330K twitter stocktwits trandingview |
Finance
| | O: 0.37% H: 0.0% C: 0.0%

deadline
Investigation Alert: Did You Lose Money on Your Investment? Johnson Fistel, LLP Encourages Investors to Contact the Firm
Published: 2021-12-05 (Crawled : 16:20) - prnewswire.com
ORGO | $2.865 2.69% 2.62% 330K twitter stocktwits trandingview |
Finance
| Email alert Add to watchlist
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SEER | $1.755 3.85% 3.7% 600K twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist
TUYA | $1.63 -1.81% 0.0% 180K twitter stocktwits trandingview |
Information
| Email alert Add to watchlist
AKU | $0.2887 -0.42% 8.5M twitter stocktwits trandingview |
Health Services
| Email alert Add to watchlist


ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Revance Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
Published: 2021-11-26 (Crawled : 19:00) - prnewswire.com
RVNC | $3.8 1.06% 1.05% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

ongoing therapeutics
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.